📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

PARNAXLABPharmaceuticals

Parnax Lab Ltd — Financial Ratios & Key Metrics

₹128.55

-2.85%

P/E Ratio12.81xIndustry: 31.77x

ROE15.14%Return on equity

ROCE13.97%Return on capital

Debt/Equity0.77Low debt

💎

Valuation & Profitability

P/E Ratio

12.81x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹141.27 (Cr)

Sales Growth 5Y

14.52%

Profit Growth 5Y

43.21%

EPS Growth 5Y

37.86%

OPM 5Y Avg

13.36%

📉

Price Returns

1 Month

-4.65%

3 Months

-6.14%

6 Months

+12.59%

1 Year

-32.06%

52W Low

₹86

Current

₹129

52W High

₹147

70% of 52-week range — Mid range

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹123

▲ Price above SMA 50 — Bullish

SMA 200

₹123

▲ Long-term uptrend

Volume Signal

339% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Parnax Lab Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.